Hepatic arterial infusion chemotherapy combined with donafenib and tislelizumab versus transcatheter chemoembolization alone for hepatocellular carcinoma: A propensity score matching study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Sun Yat-sen University Cancer Center, Sun Yat-sen University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410816984
